U.S. markets open in 51 minutes
  • S&P Futures

    3,780.50
    +15.00 (+0.40%)
     
  • Dow Futures

    30,977.00
    +99.00 (+0.32%)
     
  • Nasdaq Futures

    12,504.00
    +49.00 (+0.39%)
     
  • Russell 2000 Futures

    2,156.90
    +12.40 (+0.58%)
     
  • Crude Oil

    65.19
    +1.36 (+2.13%)
     
  • Gold

    1,693.70
    -7.00 (-0.41%)
     
  • Silver

    25.34
    -0.12 (-0.46%)
     
  • EUR/USD

    1.1913
    -0.0066 (-0.55%)
     
  • 10-Yr Bond

    1.5730
    +0.0230 (+1.48%)
     
  • Vix

    27.34
    +0.67 (+2.51%)
     
  • GBP/USD

    1.3804
    -0.0090 (-0.65%)
     
  • USD/JPY

    108.5370
    +0.5610 (+0.52%)
     
  • BTC-USD

    47,669.30
    -1,676.58 (-3.40%)
     
  • CMC Crypto 200

    954.93
    -32.28 (-3.27%)
     
  • FTSE 100

    6,664.79
    +13.91 (+0.21%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

Amyris (AMRS) Surges: Stock Moves 7.1% Higher

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Amyris, Inc. AMRS was a big mover last session, as the company saw its shares more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.This continues the recent uptrend for the company—as the stock is now up 90% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Amyris has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%.

Amyris, Inc. Price

Amyris, Inc. Price
Amyris, Inc. Price

Amyris, Inc. price | Amyris, Inc. Quote

Investors interested in the Chemical - Specialty industry may consider Balchem Corporation BCPC which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Balchem Corporation (BCPC) : Free Stock Analysis Report
 
Amyris, Inc. (AMRS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.